Ignite Creation Date:
2025-12-24 @ 3:21 PM
Ignite Modification Date:
2026-01-21 @ 3:33 PM
Study NCT ID:
NCT06881992
Status:
RECRUITING
Last Update Posted:
2025-10-21
First Post:
2025-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Sponsor:
Rezolute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
RZ358-302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None